✦ LIBER ✦

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

✍ Scribed by Grill, J.; Geoerger, B.; Gesner, L.; Perek, D.; Leblond, P.; Canete, A.; Aerts, I.; Madero, L.; de Toledo Codina, J. S.; Verlooy, J.; Estlin, E.; Cisar, L.; Breazna, A.; Dorman, A.; Bailey, S.; Nicolin, G.; Grundy, R. G.; Hargrave, D.

Book ID: 121452112
Publisher: Duke University Press
Year: 2013
Tongue: English
Weight: 113 KB
Volume: 15
Category: Article
ISSN: 1522-8517
DOI: 10.1093/neuonc/not097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II single-arm study of irinoteca

A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study

✍ Darren Hargrave, Birgit Geoerger, Didier Frappaz… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 197 KB

Phase I Study of Vismodegib in Children

Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study

✍ Gajjar, A.; Stewart, C. F.; Ellison, D. W.; Kaste, S.; Kun, L. E.; Packer, R. J. 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 436 KB

Phase II study of oxaliplatin in childre

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors : A pediatric brain tumor consortium study

✍ Maryam Fouladi; Susan M. Blaney; Tina Young Poussaint; Burgess B. Freeman III; R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Phase II study of temozolomide in combin

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

✍ Di Giannatale, Angela; Dias-Gastellier, Nathalie; Devos, Annick; Mc Hugh, Kieran 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 750 KB

Phase II study of a protracted irinoteca

Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma

✍ Gianni Bisogno; Riccardo Riccardi; Antonio Ruggiero; Giampaolo Arcamone; Arcange 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## BACKGROUND Irinotecan (CPT‐11) is a novel antineoplastic agent that takes effect by inhibiting topoisomerase I. The Italian Soft Tissue Sarcoma (STS) Committee performed a multiinstitutional Phase II study to evaluate its effect on STS. ## METHODS Over a 2‐year period between 2002

Pilot study of vincristine, oral irinote

Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors

✍ Wagner, Lars; Turpin, Brian; Nagarajan, Rajaram; Weiss, Brian; Cripe, Timothy; G 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB